Form 8-K - Current report:
SEC Accession No. 0001437749-20-005893
Filing Date
2020-03-23
Accepted
2020-03-23 15:52:11
Documents
4
Period of Report
2020-03-12
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20200313_8k.htm 8-K 49070
2 EXHIBIT 10.1 ex_177239.htm EX-10.1 131692
3 EXHIBIT 10.2 ex_177240.htm EX-10.2 119900
4 EXHIBIT 99.1 ex_177241.htm EX-99.1 13624
  Complete submission text file 0001437749-20-005893.txt   315619
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 20734876
SIC: 2834 Pharmaceutical Preparations